Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI

INTRODUCTION: Prostate cancer is a leading cause of cancer death among men in the Western world. Early detection of prostate cancer has been shown to decrease mortality, but has limitations with low specificity leading to unnecessary biopsies and overdiagnosis of low-risk cancers. The STHLM3 trial h...

Descripción completa

Detalles Bibliográficos
Autores principales: Nordström, Tobias, Jäderling, Fredrik, Carlsson, Stefan, Aly, Markus, Grönberg, Henrik, Eklund, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Urology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6576112/
https://www.ncbi.nlm.nih.gov/pubmed/31201191
http://dx.doi.org/10.1136/bmjopen-2018-027816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6576112/
https://www.ncbi.nlm.nih.gov/pubmed/31201191
http://dx.doi.org/10.1136/bmjopen-2018-027816

Ejemplares similares